Cabio Biotech (Wuhan) Co., Ltd. (SHA:688089)
China · Delayed Price · Currency is CNY 20.35
-0.03 (-0.15%)
At close: Jan 23, 2026
Cabio Biotech (Wuhan) Market Cap
Cabio Biotech (Wuhan) has a market cap or net worth of 3.39 billion as of January 23, 2026. Its market cap has increased by 3.85% in one year.
Market Cap
3.39B
Enterprise Value
3.25B
Revenue
596.47M
Ranking
n/a
PE Ratio
20.15
Stock Price
20.35
Market Cap Chart
Since December 19, 2019, Cabio Biotech (Wuhan)'s market cap has decreased from 5.54B to 3.39B, a decrease of -38.73%. That is a compound annual growth rate of -7.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 3.39B | -12.59% |
| Dec 31, 2025 | 3.88B | 21.24% |
| Dec 31, 2024 | 3.20B | 6.31% |
| Dec 29, 2023 | 3.01B | -44.60% |
| Dec 30, 2022 | 5.44B | -26.24% |
| Dec 31, 2021 | 7.37B | 55.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Shen Lian Biomedical | 4.09B |
| Qingdao Vland Biotech INC. | 4.01B |
| Yantai Zhenghai Biotechnology | 3.89B |
| Beijing Kawin Technology Share-Holding | 3.86B |
| Baolingbao Biology | 3.82B |
| Shanghai Model Organisms Center | 3.71B |
| Novoprotein Scientific | 3.49B |
| Guangdong VTR Bio-Tech | 3.42B |